Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

458
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
458
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

93
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
93
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

95
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
95
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

579
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
579
Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

131
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
131
Endoscopic Procedures V: ERCP01:26

Endoscopic Procedures V: ERCP

279
Endoscopic Retrograde Cholangiopancreatography (ERCP) is a diagnostic procedure that combines endoscopy and fluoroscopy to diagnose and treat conditions related to the bile ducts, pancreatic ducts, and gallbladder. This procedure is beneficial for identifying and addressing blockages, gallstones, strictures, and tumors within the biliary or pancreatic systems. ERCP is both diagnostic and therapeutic, offering the ability to visualize and treat identified problems in one session.
Patient...
279

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of non-selective beta-blockers on acute kidney injury outcomes in patients with decompensated cirrhosis.

Journal of hepatology·2026
Same author

[Hepatic Overlap Syndrome: Primary Sclerosing Cholangitis and Primary Biliary Cholangitis. Case Review].

Revista medica de Chile·2026
Same author

Prevalence and Predictors of MASLD and Fibrosis in an Urban Outpatient Setting: A Cross-Sectional Study.

Journal of clinical medicine·2026
Same author

Exploring the interaction between metabolic dysfunction and alcohol-associated hepatitis: A global study.

Hepatology (Baltimore, Md.)·2026
Same author

Increased Intrahepatic Mast Cell Density in Liver Cirrhosis Due to MASLD and Other Non-Infectious Chronic Liver Diseases.

International journal of molecular sciences·2026
Same author

Impact of age on autoimmune hepatitis: A comparative study of patients diagnosed before and after sixty.

World journal of hepatology·2026

Related Experiment Video

Updated: Jul 12, 2025

Laparoscopic Common Bile Duct Exploration in Patients with a Previous History of Biliary Tract Surgery
07:36

Laparoscopic Common Bile Duct Exploration in Patients with a Previous History of Biliary Tract Surgery

Published on: February 10, 2023

1.8K

[Primary biliary cholangitis. Experience in 179 patients].

Felipe Ramírez1, Álvaro Urzúa1, Juan Pablo Roblero1

  • 1Sección de Gastroenterología, Departamento de Medicina Interna, Hospital Clínico Universidad de Chile, Santiago, Chile.

Revista Medica De Chile
|October 31, 2023
PubMed
Summary

Primary biliary cholangitis (PBC) predominantly affects middle-aged women and often presents asymptomatically with cholestasis and antimitochondrial antibodies (AMA). Diagnosis can be made without biopsy, and ursodeoxycholic acid (UDCA) is the primary treatment.

More Related Videos

A Two-Step Method for Percutaneous Transhepatic Choledochoscopic Lithotomy
03:56

A Two-Step Method for Percutaneous Transhepatic Choledochoscopic Lithotomy

Published on: September 13, 2022

2.4K
Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb
04:50

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb

Published on: January 17, 2025

264

Related Experiment Videos

Last Updated: Jul 12, 2025

Laparoscopic Common Bile Duct Exploration in Patients with a Previous History of Biliary Tract Surgery
07:36

Laparoscopic Common Bile Duct Exploration in Patients with a Previous History of Biliary Tract Surgery

Published on: February 10, 2023

1.8K
A Two-Step Method for Percutaneous Transhepatic Choledochoscopic Lithotomy
03:56

A Two-Step Method for Percutaneous Transhepatic Choledochoscopic Lithotomy

Published on: September 13, 2022

2.4K
Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb
04:50

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb

Published on: January 17, 2025

264

Area of Science:

  • Hepatology
  • Autoimmune diseases
  • Gastroenterology

Context:

  • Primary biliary cholangitis (PBC) is a chronic, autoimmune, cholestatic liver disease.
  • PBC primarily affects middle-aged women and can lead to cirrhosis.
  • Diagnosis frequently involves biochemical cholestasis and antimitochondrial antibodies (AMA).

Purpose:

  • To delineate the epidemiological profile of PBC patients.
  • To characterize the clinical presentation and treatment patterns of PBC.
  • To assess PBC comorbidities within a specific clinical hospital setting.

Summary:

  • A retrospective study analyzed 179 PBC patients (158 female), with a median age of 54 at diagnosis.
  • Common presentations included asymptomatic disease (55%), fatigue (45%), and pruritus (28%). Positive AMA were found in 65% of patients.
  • Associated conditions included Sjogren's syndrome (15%), hypothyroidism (14%), and osteoporosis (13%). Ursodeoxycholic acid (UDCA) is the standard first-line therapy.

Impact:

  • Findings align with international PBC epidemiological data.
  • Confirms AMA and biochemical markers enable diagnosis, reducing the need for liver biopsy.
  • Highlights the importance of biochemical response monitoring for optimizing UDCA treatment strategies.